Julia A Beaver

6PUBLICATIONS
64CO-AUTHORS
AvionicsGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Flight dynamics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 25, 2023
FDA Approval Summary: Alpelisib for PIK3CA-Related Overgrowth Spectrum.

Sonia Singh, Diana Bradford, Xiaoxue Li

|Apr 06, 2023
FDA Approval Summary: Amivantamab for the Treatment of Patients with Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations.

Katie Chon, Erin Larkins, Somak Chatterjee

|Mar 23, 2023
FDA Approval Summary: Atezolizumab as Adjuvant Treatment following Surgical Resection and Platinum-Based Chemotherapy for Stage II to IIIA NSCLC.

Luckson N Mathieu, Erin Larkins, Arup K Sinha

|Sep 16, 2022
FDA Approval Summary: Mobocertinib for Metastatic Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations.

Elizabeth S Duke, Liza Stapleford, Nicole Drezner

|Aug 12, 2022
FDA Approval Summary: Nivolumab for the Adjuvant Treatment of Adults with Completely Resected Esophageal/Gastroesophageal Junction Cancer and Residual Pathologic Disease.

M Naomi Horiba, Sandra J Casak, Pallavi S Mishra-Kalyani

|Aug 04, 2022
FDA Approval Summary: Pembrolizumab for Neoadjuvant and Adjuvant Treatment of Patients with High-Risk Early-Stage Triple-Negative Breast Cancer.

Mirat Shah, Christy L Osgood, Anup K Amatya

Pageof 1

Frequent Collaborators

5 joint publications

Richard Pazdur

5 joint publications

Pallavi S Mishra-Kalyani

4 joint publications

Harpreet Singh

3 joint publications

Jiang Liu